Keyphrases
Liposoluble Constituent
100%
Cancer Patients
100%
In Cancer
100%
Amphotericin B
100%
Neutropenia
100%
Conventional Amphotericin B
100%
Confidence Interval
85%
Relative Risk
85%
Nephrotoxicity
42%
Invasive Fungal Infection
28%
Lipid-based Formulation
28%
AmBisome
28%
No Significant Difference
14%
Drug Use
14%
Serum Creatinine
14%
Randomized Clinical Trial
14%
PubMed
14%
High Cost
14%
Potassium
14%
Magnesium
14%
Large Trials
14%
Life-threatening
14%
Chemotherapy
14%
Dropout
14%
Patients with Cancer
14%
Premedication
14%
Fever
14%
Antifungal Drugs
14%
Risk of Bias
14%
Intralipid
14%
Fungal Infection
14%
Bone Marrow Transplantation
14%
Review Authors
14%
Trial Eligibility
14%
Amphotericin B Lipid Complex
14%
Amphotericin B Colloidal Dispersion
14%
Lipid-based
14%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Amphotericin B
100%
Neutropenia
100%
Nephrotoxicity
20%
Amphotericin B Lipid Complex
20%
Systemic Mycosis
13%
Creatinine
6%
Randomized Clinical Trial
6%
Infection
6%
Isotopes of Potassium
6%
Chemotherapy
6%
Antifungal Agent
6%
Intralipid
6%
Mycosis
6%
Reduced Nicotinamide Adenine Dinucleotide Dehydrogenase (Ubiquinone)
6%
Haemophilus Influenzae Type B Vaccine
6%
Medicine and Dentistry
Neutropenia
100%
Amphotericin B
100%
Nephrotoxicity
20%
Amphotericin B Lipid Complex
20%
Systemic Mycosis
13%
Supplementation
6%
Infection
6%
Randomized Clinical Trial
6%
Health Care Cost
6%
Infusion
6%
Magnesium
6%
Creatinine
6%
Premedication
6%
Antifungal Agent
6%
Intralipid
6%
Mycosis
6%
Bone Marrow Transplantation
6%
Reduced Nicotinamide Adenine Dinucleotide Dehydrogenase (Ubiquinone)
6%
Haemophilus Influenzae Type B Vaccine
6%